Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2009 4
2010 9
2011 7
2012 6
2013 8
2014 5
2015 8
2016 5
2017 7
2018 9
2019 4
2020 3
2021 10
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease.
Portman MA, Jacobs JP, Newburger JW, Berger F, Grosso MA, Duggal A, Tao B, Goldenberg NA; ENNOBLE-ATE Trial Investigators. Portman MA, et al. J Am Coll Cardiol. 2022 Dec 13;80(24):2301-2310. doi: 10.1016/j.jacc.2022.09.031. Epub 2022 Oct 31. J Am Coll Cardiol. 2022. PMID: 36328157 Free article. Clinical Trial.
Adolescents and young adults with newly diagnosed primary immune thrombocytopenia.
Schifferli A, Moulis G, Godeau B, Leblanc T, Aladjidi N, Michel M, Leverger G, Elalfy M, Grainger J, Chitlur M, Heiri A, Holzhauer S, Le Gavrian G, Imbach P, Kühne T. Schifferli A, et al. Among authors: elalfy m. Haematologica. 2023 Oct 1;108(10):2783-2793. doi: 10.3324/haematol.2022.282524. Haematologica. 2023. PMID: 37051753 Free PMC article.
Efficacy and safety of early-start deferiprone in infants and young children with transfusion-dependent beta thalassemia: Evidence for iron shuttling to transferrin in a randomized, double-blind, placebo-controlled, clinical trial (START).
Elalfy MS, Hamdy M, Adly A, Ebeid FSE, Temin NT, Rozova A, Lee D, Fradette C, Tricta F. Elalfy MS, et al. Am J Hematol. 2023 Sep;98(9):1415-1424. doi: 10.1002/ajh.27010. Epub 2023 Jul 4. Am J Hematol. 2023. PMID: 37401738 Clinical Trial.
Epistaxis in a Pediatric Outpatient Clinic: Could It be an Alarming Sign?
ElAlfy MS, Tantawy AAG, Eldin BEMB, Mekawy MA, Mohammad YAE, Ebeid FSE. ElAlfy MS, et al. Int Arch Otorhinolaryngol. 2021 Jun 3;26(2):e183-e190. doi: 10.1055/s-0041-1726040. eCollection 2022 Apr. Int Arch Otorhinolaryngol. 2021. PMID: 35602268 Free PMC article.
Determination of Human Hemoglobin Derivatives.
Attia AM, Ibrahim FA, Abd El-Latif NA, Aziz SW, Abdelmottaleb Moussa SA, Elalfy MS. Attia AM, et al. Among authors: elalfy ms. Hemoglobin. 2015;39(5):371-4. doi: 10.3109/03630269.2015.1062775. Epub 2015 Jul 21. Hemoglobin. 2015. PMID: 26193973
Diagnosis and management of chronic ITP: comments from an ICIS expert group.
Grainger JD, Bolton-Maggs PH, Godeau B, Bussel J, Donato H, Elalfy M, Hainmann I, Matzdorff A, Müller-Beissenhirtz H, Rovó A, Tichelli A. Grainger JD, et al. Among authors: elalfy m. Ann Hematol. 2010 Jul;89 Suppl 1:11-7. doi: 10.1007/s00277-010-0950-0. Epub 2010 May 7. Ann Hematol. 2010. PMID: 20449748 Review.
Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open-label FIRST study.
Hamdy M, El-Beshlawy A, Veríssimo MPA, Kanter J, Inusa B, Williams S, Lee D, Temin NT, Fradette C, Tricta F, Ebeid FSE, Kwiatkowski JL, Elalfy MS. Hamdy M, et al. Among authors: elalfy ms. Pediatr Blood Cancer. 2024 Jan;71(1):e30711. doi: 10.1002/pbc.30711. Epub 2023 Oct 9. Pediatr Blood Cancer. 2024. PMID: 37807937 Clinical Trial.
82 results